Literature DB >> 26828359

The Roles of MicroRNA-141 in Human Cancers: From Diagnosis to Treatment.

Yanping Gao1, Bing Feng, Siqi Han, Kai Zhang, Jing Chen, Chen Li, Rui Wang, Longbang Chen.   

Abstract

Cancer remains one of the most threatening causes of human health impairment, and the mechanisms underlying tumorigenesis have not been completely characterized. MicroRNAs (miRNAs) are a group of endogenous, small (18∼25 nucleotides) non-coding RNAs which negatively regulate gene expressions by directly binding to the 3'-untranslated regions (3'-UTRs) of the target messenger RNAs (mRNAs). Increasing evidence has demonstrated abnormal miRNA profiles and confirmed their involvement in tumor initiation and progression. As one important member of the miR-200 family, microRNA (miR)-141 is aberrantly expressed in many human malignant tumors, participating in various cellular processes including epithelial-mesenchymal transition (EMT), proliferation, migration, invasion, and drug resistance. In the present review, we briefly describe the mechanisms underlying miR-141-mediated tumorigenesis and the possible future of miR-141 as a potential diagnostic and prognostic parameter as well as therapeutic target in clinical applications.
© 2016 The Author(s) Published by S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26828359     DOI: 10.1159/000438641

Source DB:  PubMed          Journal:  Cell Physiol Biochem        ISSN: 1015-8987


  24 in total

1.  Circulating miR-141 as a potential biomarker for diagnosis, prognosis and therapeutic targets in gallbladder cancer.

Authors:  Ganghua Yang; Zhengyang Lu; Fandi Meng; Yong Wan; Lei Zhang; Qinhong Xu; Zheng Wang
Journal:  Sci Rep       Date:  2022-06-16       Impact factor: 4.996

2.  Interleukin-8 Dedifferentiates Primary Human Luminal Cells to Multipotent Stem Cells.

Authors:  Huda H Al-Khalaf; Hazem Ghebeh; Salma M Wakil; Falah Al-Mohanna; Abdelilah Aboussekhra
Journal:  Mol Cell Biol       Date:  2020-04-13       Impact factor: 4.272

3.  Non-target Genes Regulate miRNAs-Mediated Migration Steering of Colorectal Carcinoma.

Authors:  Sohair M Salem; Ahmed R Hamed; Alaaeldin G Fayez; Ghada Nour Eldeen
Journal:  Pathol Oncol Res       Date:  2018-10-25       Impact factor: 3.201

4.  Novel circulating microRNAs expression profile in colon cancer: a pilot study.

Authors:  Ya-Nan Wang; Zhao-Hua Chen; Wei-Chang Chen
Journal:  Eur J Med Res       Date:  2017-11-29       Impact factor: 2.175

5.  Identification of novel diagnostic and prognostic miRNA signatures in endometrial cancer.

Authors:  Muralidharan Jayaraman; Rangasudhagar Radhakrishnan; Cara A Mathews; Mingda Yan; Sanam Husain; Katherine M Moxley; Yong Sang Song; Danny N Dhanasekaran
Journal:  Genes Cancer       Date:  2017-05

6.  Comparison of the miRNA expression profiles in fresh frozen and formalin-fixed paraffin-embedded tonsillar tumors.

Authors:  Zuzana Vojtechova; Jiri Zavadil; Jan Klozar; Marek Grega; Ruth Tachezy
Journal:  PLoS One       Date:  2017-06-23       Impact factor: 3.240

Review 7.  Expression signatures and roles of MicroRNAs in human oesophageal adenocarcinomas.

Authors:  Xiangyi Kong; Shun Gong; Lijuan Su; Chen Li; Yanguo Kong
Journal:  J Cell Mol Med       Date:  2017-08-10       Impact factor: 5.310

8.  High-Sensitivity Dual-Probe Detection of Urinary miR-141 in Cancer Patients via a Modified Screen-Printed Carbon Electrode-Based Electrochemical Biosensor.

Authors:  Wai-Hung Leung; Chi-Chia Pang; Sow-Neng Pang; Sheng-Xiang Weng; Yu-Lun Lin; Yueh-Er Chiou; See-Tong Pang; Wen-Hui Weng
Journal:  Sensors (Basel)       Date:  2021-05-03       Impact factor: 3.576

9.  Molecular subtyping of nasopharyngeal carcinoma (NPC) and a microRNA-based prognostic model for distant metastasis.

Authors:  Lan Zhao; Alvin H W Fong; Na Liu; William C S Cho
Journal:  J Biomed Sci       Date:  2018-02-19       Impact factor: 8.410

10.  CircKEAP1 Suppresses the Progression of Lung Adenocarcinoma via the miR-141-3p/KEAP1/NRF2 Axis.

Authors:  Yanbo Wang; Fenghai Ren; Dawei Sun; Jing Liu; BenKun Liu; YunLong He; Sainan Pang; BoWen Shi; FuCheng Zhou; Lei Yao; YaoGuo Lang; ShiDong Xu; JunFeng Wang
Journal:  Front Oncol       Date:  2021-05-31       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.